AR022321A1 - USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE - Google Patents

USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE

Info

Publication number
AR022321A1
AR022321A1 ARP000100250A ARP000100250A AR022321A1 AR 022321 A1 AR022321 A1 AR 022321A1 AR P000100250 A ARP000100250 A AR P000100250A AR P000100250 A ARP000100250 A AR P000100250A AR 022321 A1 AR022321 A1 AR 022321A1
Authority
AR
Argentina
Prior art keywords
treatment
transformed
migrane
convulsive
derivatives
Prior art date
Application number
ARP000100250A
Other languages
Spanish (es)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR022321A1 publication Critical patent/AR022321A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Se describen derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada.Anticonvulsant derivatives useful for the treatment of transformed migraine are described.

ARP000100250A 1999-01-21 2000-01-20 USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE AR022321A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11654499P 1999-01-21 1999-01-21

Publications (1)

Publication Number Publication Date
AR022321A1 true AR022321A1 (en) 2002-09-04

Family

ID=22367829

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100250A AR022321A1 (en) 1999-01-21 2000-01-20 USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE

Country Status (3)

Country Link
AR (1) AR022321A1 (en)
AU (1) AU3582600A (en)
WO (1) WO2000042995A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AR058389A1 (en) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
WO2007137167A2 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
EA018567B1 (en) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN110346004B (en) * 2019-08-16 2020-08-21 杭州山科智能科技股份有限公司 Flow measurement data fusion method of dual-channel ultrasonic time difference method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
ATE226071T1 (en) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN

Also Published As

Publication number Publication date
WO2000042995A2 (en) 2000-07-27
AU3582600A (en) 2000-08-07
WO2000042995A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
ES2184127T3 (en) DERIVATIVES OF USEFUL ANTI-CONVULSIVE SULFAMATE FOR THE TREATMENT OF OBESITY.
NO20005237D0 (en) Heterocyclic substituted amides used as calpain inhibitors
DK0840732T3 (en) Substituted benzolactam compounds as substance P antagonists
DK1193270T3 (en) pyrrolobenzodiazepines
ATE302770T1 (en) BENZIMIDAZOLE COMPOUNDS THAT HAVE NOCICEPTINE RECEPTOR AFFINITY
GB9801690D0 (en) Therapeutic agents
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
AR022321A1 (en) USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE
DK1097173T3 (en) Use of IL-2 peptides and derivatives thereof as therapeutic agents
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
SE9901077D0 (en) Novel use
BR9807883A (en) Tetrahydropyride compounds
SE9801494D0 (en) Novel use
EA200100854A1 (en) CALCIUM-LITICAL COMPOUNDS
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
BR9902084A (en) Heterocycles.
IT1306165B1 (en) USE OF INHIBITORS OF THE SUBSTANCE P FOR THE TREATMENT OF DENOCARCINOMAS.
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors
DE69936052D1 (en) N1 MODIFIED GLYCOPEPTIDE
ECSP003590A (en) CALCIOLITIC COMPOUNDS
DK1017681T3 (en) Hydrazone-benzazulin derivatives, pharmaceuticals and intermediates
NO20005548D0 (en) Mykobakterieinhibitorer
EA200500878A1 (en) CALCYLYTIC COMPOUNDS
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives